Abstract : BACKGROUND: Mycobacterium mucogenicum is a rare but emerging cause of infections, especially in immunocompromised patients.
METHODS: We describe a new case of M. mucogenicum catheter-related bloodstream infection in a 34-year-old woman with ovarian cancer. M. mucogenicum was at first considered as a contaminant, and susceptibility testing was not performed. Usual susceptibility of M. mucogenicum motivated prescription of clarithromycin and moxifloxacin. Finally, our isolate was confirmed susceptible to both drugs. Clinical outcome was favorable with no relapse of infection after antibiotics discontinuation despite concomitant chemotherapy.
CONCLUSIONS: Our case illustrates the need for a clinician-microbiologist dialogue in case of suspected M. mucogenicum infection to avoid delaying appropriate management.
https://hal.univ-lille.fr/hal-02526469
Contributeur : Lilloa Université de Lille <>
Soumis le : mardi 31 mars 2020 - 16:00:29 Dernière modification le : mardi 3 novembre 2020 - 15:54:06
Maxime Pradier, Anne Boucher, Olivier Robineau, Elisabeth Chachaty, Agnes Meybeck, et al.. Mycobacterium mucogenicum bacteremia: major role of clinical microbiologists. BMC Infectious Diseases, BioMed Central, 2019, 18, pp.646. ⟨10.1186/s12879-018-3545-3⟩. ⟨hal-02526469⟩